Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.
- Revenue
- +8.06%
- EPS
- +8.47%
- Free cash flow
- +69.5%
- Total debt
- +8.81%
Quarter to July 2026, against a year earlier
Follow A
Alert me
Agilent Technologies, Inc. 10-Q filed Aug 29, 2025
What changed
Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Jun 2, 2025: 9 added · 10 removed · 64 modified; 20 with only figures updated
-
Modified · Executive Summary
Global Tariffs. Recent changes to tariffs and trade policies by the U.S. and other countries have increased risk and uncertainty surrounding our future results of operations.
While theseIn the first half of fiscal year 2025, changeshad noto tariffs and trade policies did not have a material impact on our resultsinof operations. In thefirstsecond half of fiscal year 2025,we observed increased demand for laboratory consumables in the second quarter which we believe is attributable to customers seeking to mitigate the potential impact of the proposedthe U.S. government introduced additional measures related to tariffs, including certain increases, exemptions and pauses, and other countries have responded with preliminary agreements and retaliatory actions. The ultimate impact of changes to tariffs and trade policiesannounced in April 2025. This increased demand in laboratory consumables was offset by customs-related delays in instrument shipmentswill depend on various factors, including the timing, amount, scope, and nature of any tariffs or trade policies implemented and our ability to respond to mitigate the impact of such tariffs and trade policies. We continue to monitor these evolving trade dynamics closely, as they may influence future revenue and operational efficiency.